Irinotecan Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Irinotecan Hydrochloride Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on 02/24/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Ingenus Pharmaceuticals LLC
- Package NDC
- 50742-401-02
- Dosage Form
- Injection
- Presentation
- Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)
- Initial Posting
- 02/24/2026
- Revised Date